Predicting adherence to therapy with glatiramer acetate administered with pre-filled syringes in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Zwibel, H
Pardo, G
Smith, S
Denney, D
机构：
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [41] Insights from the Coptimize study: characteristics of relapsing-remitting multiple sclerosis patients switching to glatiramer acetate
    Ziemssen, T.
    Carra, A.
    De Klippel, N.
    de Sa, J.
    Frederiken, J.
    Heinzlef, O.
    Karageorgiou, C.
    Kovacs, K.
    Landtblom, A.
    Lisy, L.
    Bajenaru, O.
    Tsai, C.
    Tubridy, N.
    Vorobeychik, G.
    Macias, M.
    Edland, A.
    Lander, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S218 - S218
  • [42] Gene expression profile and clinical outcome in relapsing-remitting multiple sclerosis patients treated with glatiramer acetate
    Achiron, Anat
    Magalashvili, David
    Dolev, Mark
    Sonis, Polina
    Gurevich, Michael
    [J]. NEUROLOGY, 2007, 68 (12) : A313 - A314
  • [43] Clinical response to glatiramer acetate in interferon beta-resistant relapsing-remitting multiple sclerosis patients
    Bermejo, Pedro E.
    Oreja-Guevara, Celia
    Miralles, Ambrosio
    Aguilar, Maria J.
    Diez-Tejedor, Exuperio
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S32 - S32
  • [44] Glatiramer Acetate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
    Scott, Lesley J.
    [J]. CNS DRUGS, 2013, 27 (11) : 971 - 988
  • [45] Glatiramer Acetate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
    Lesley J. Scott
    [J]. CNS Drugs, 2013, 27 : 971 - 988
  • [46] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [47] A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
    Voskuhl, R.
    Wang, H.
    Lee, G.
    Giesser, B.
    Tse, C. H.
    Elashoff, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 44 - 44
  • [48] Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis
    Khan, O
    Shen, YM
    Caon, C
    Bao, F
    Ching, W
    Reznar, M
    Buccheister, A
    Hu, JN
    Latif, Z
    Tselis, A
    Lisak, R
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (06) : 646 - 651
  • [49] Impact of age on treatment decisions and adherence to therapy in patients with relapsing-remitting multiple sclerosis
    Sorensen, P. S.
    Joensen, H.
    Sellebjerg, F.
    Magyari, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 762 - 763
  • [50] Tolerability and Safety of Combined Glatiramer Acetate and N-Acetylcysteine in Relapsing-Remitting Multiple Sclerosis
    Schipper, Hyman M.
    Arnold, Douglas
    Grand'Maison, Francois
    Melmed, Calvin
    Moore, Fraser
    Levental, Mark
    Su, Haixiang
    Constantin, Michel
    Stril, Jean-Louis
    Godin, Jean
    [J]. CLINICAL NEUROPHARMACOLOGY, 2015, 38 (04) : 127 - 131
12345